Human Immunodeficiency Virus Type 1 Resistance to the Small Molecule Maturation Inhibitor 3-O-(3′,3′-Dimethylsuccinyl)-Betulinic Acid Is Conferred by a Variety of Single Amino Acid Substitutions at the CA-SP1 Cleavage Site in Gag

Ítems similars

• The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid
  per: Zhou, Jing, et al.
  Publicat: (2004)
• 3-O-(3′,3′-Dimethysuccinyl) Betulinic Acid Inhibits Maturation of the Human Immunodeficiency Virus Type 1 Gag Precursor Assembled In Vitro
  per: Sakalian, Michael, et al.
  Publicat: (2006)
• HIV-1 Maturation Inhibitor Bevirimat Stabilizes the Immature Gag Lattice
  per: Keller, Paul W., et al.
  Publicat: (2011)
• Functional Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness
  per: Brann, Terrence W., et al.
  Publicat: (2006)
• Positive Selection Pressure Introduces Secondary Mutations at Gag Cleavage Sites in Human Immunodeficiency Virus Type 1 Harboring Major Protease Resistance Mutations
  per: Banke, Søren, et al.
  Publicat: (2009)